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Abstract: A secondary metabolite, 2ʹ-O-ethylmurrangatin (1), was isolated from the leaves of a medicinal plant,
Murraya paniculata. The structure of compound 1 was identified with the help of spectroscopic techniques. Compound
1 was screened for its antioxidant, lipoxygenase, prolyl endopeptidase, and respiratory burst inhibitory activities.
2ʹ-O-Ethylmurrangatin (1) was found to have significant activity against lipoxygenase enzyme and moderate respiratory
burst inhibitory activity, but no activity against either DPPH radical scavenging assay or prolyl endopeptidase enzyme.
Key words: Murraya paniculata, Rutaceae, 2ʹ-O-ethylmurrangatin, antioxidant, DPPH radical scavenging assay,
lipoxygenase inhibition assay, prolyl endopeptidase inhibition assay, respiratory burst inhibitory assay

Introduction
Murraya paniculata (L.) Jack or Orange Jasmine
belongs to the family Rutaceae, and occurs widely in
India, southeast Asia, southern China, and the Malay
Peninsula. The leaves are used for the treatment of
diarrhea and dysentery. Leaves and root barks are also
used against rheumatism, cough, and hysteria. The
leaves possess antibiotic activity against Micrococcus
pyogenes var. aureus and Escherichia coli (1,2).
Previous phytochemical studies on this plant have
resulted in the isolation of a new natural product,
2´-O-ethylmurrangatin (1) along with 2 known
coumarins, and their anti-acetylcholinesterase
and anti-butyrylcholinesterase activities were also
studied (3). We now report here the antioxidant,
lipoxygenase, prolyl endopeptidase, and respiratory

burst inhibitory activities of 2´-O-ethylmurrangatin
(1).
Antioxidants can inhibit the oxidation of
oxidizable materials in living cells. Free radicals are
generated as a result of oxidation (4), and may be
involved in the pathogenesis of various diseases such
as cancers. They may also cause many other diseases
like heart diseases, diabetes, arteriosclerosis, and
arthritis (5). Antioxidants retard such processes as
premature aging (6), cancers (7), and heart diseases
(8) by inhibition of certain enzymes, quenching free
radicals, and may result in reactive oxygen species
(ROS) (4) during their catalytic reactions.
Lipoxygenases constitute a family of nonheam iron containing dioxygenases that are widely
found in animals and plants. In mammalian cells,
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these are the key enzymes in the biosynthesis of
a variety of bioregulatory compounds such as
hydroxyeicosatetraenoic acids (HETEs), leukotrienes,
lipoxins, and hepoxylines (9). Lipoxygenase products
play an important role in a variety of disorders such
as bronchial asthma, inflammation (10), autoimmune
diseases, and tumor angiogenesis (11). Lipoxygenases
are therefore potential targets for the rational drug
design and discovery of mechanism-based inhibitors
for the treatment of these diseases.
Prolyl endopeptidase (PEP) or post-proline
cleaving enzyme (EC. 3.4.21.26) catalyzes the
cleavage of the peptide bonds at the carbonyl side
of proline residue (12,13). This enzyme is widely
distributed in various organs, particularly in the
human brain. The abnormal PEP levels may be
related to neuropathological disorders, such as
major depression, mania, schizophrenia, and senile
dementia of Alzheimer’s type. PEP also plays a key role
in the regulation of blood pressure by participating in
the rennin-angiotensin system through metabolism
of bradykinin and angitensins II and I. Thus specific
inhibitors of PEP are expected to have anti-amnesic
and other effects.
Inflammation occurs as a defensive response,
which induces physiological adaptations to limit
tissue damage and remove the pathogenic infections.
Such mechanisms involve a complex series of events
including dilatation of arterioles, venules, and
capillaries with increased vascular permeability and
exudation of fluids including plasma proteins and
leukocyte migration into the inflammatory area.
For this purpose, they are equipped with various
defensive mechanisms using different proteins and
signaling pathways. Respiratory burst activity is one
of the major molecular mechanisms of neutrophils,
which play an important role in the inflammatory
responses. Compounds that exhibit respiratory
burst inhibitory activity may have potential as antiinflammatory agents.
Materials and methods
General Experimental Procedures
The 1H-NMR spectra were recorded in CDCl3 on
a Bruker AM-400 NMR spectrometer with TMS as an
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internal standard using the UNIX operating system
at 400 MHz. The 13C-NMR spectra were recorded
in CDCl3 at 125 MHz on a Bruker AMX-500 NMR
spectrometer. HREI-MS were recorded on Jeol JMS
600 and HX 110 mass spectrometers with the data
system DA 5000. The IR spectra were recorded on a
Jasco A-302 spectrophotometer. The UV spectra were
recorded on a Hitachi U-3200 spectrophotometer.
The optical rotations were measured on a JASCO
DIP-360 digital polarimeter. The melting point was
determined on a Buchi 510 apparatus. Column
chromatography (CC) was carried out on a silica
gel column (70-230 mesh). Purity of the samples
was checked by TLC on pre-coated silica gel GF254 preparative plates (20 ´ 20 cm, 0.25 mm thick,
Merck) and were detected under UV light (254 and
366 nm), while ceric sulfate was used as spraying
reagent. Lipoxygenase (EC. 1.13.11.12) (5-LOX) type
I-B (isolated from Soybean) and linoleic acid were
purchased from Sigma (St. Louis, MO, USA). Prolyl
endopeptidase (Flavobacterium meningosepticum
origin) was purchased from Seikagaku Corporation
(Tokyo, Japan), N-benzyloxycarbonyl-Gly-PropNA was procured from Bachem Fine Chemicals
Co., and bacitracin was purchased from Sigma
Co., Ltd. Dr. Hideaki Shimizu (Yakult Central
Institute for Microbiological Research, Tokyo,
Japan) has kindly gifted a specific inhibitor of PEP,
N-benzyloxycarbonyl-pro-prolinal. WST-1 was
purchased from Dojindo Laboratories (Kumamoto,
Japan). Zymosan A was purchased from Sigma
Chemicals (St. Louis, MO, USA), while FicollPaque was purchased from the Pharmacia Biotech
Amersham (Uppsala, Sweden). All reagents were
of analytical grade. Deionized water was used in all
experimental procedures.
DPPH (1,1-diphenyl-2-picryl hydrazyl) free
radical scavenging antioxidant assay
Antioxidant activity was assayed by using a nonphysiological DPPH free radical scavenging assay.
Different concentrations of test compounds were
taken in reaction mixture, ranging from 1000 to
10 μM, while the concentration of DPPH was kept
constant as 300 μM. The reaction mixture containing
5 μL of test compound in DMSO (1 mM) and 95 μL
of DPPH in ethanol (300 μM) was taken in 96-well
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microtiter plates (Molecular Devices, SpectraMax
340, USA) and incubated at 37 °C for 30 min. The
absorbance was measured at 515 nm. Percent
radical scavenging activity by test compounds was
determined in comparison of the DMSO treated
control group. IC50 values represent the concentration
of compounds required to scavenge 50% of DPPH
free radicals, which were calculated by using the EZFit Enzyme Kinetics program (Perrella Scientific Inc.,
Amherst, MA, USA). Propyl gallate (PG) was used as
a positive control (14,15).
Lipoxygenase inhibition assay
Lipoxygenase (EC. 1.13.11.12) inhibiting activity
was conveniently measured by modifying the
spectrophotometric method developed by Tappel
(16). The reaction mixture, containing 165 mL of
100 mM sodium phosphate buffer (pH 8.0), 10 mL of
test compound solution, and 20 mL of lipoxygenase
solution, was incubated for 10 min at 25 °C. The
reaction was then initiated by the addition of 10 mL of
linoleic acid (substrate) solution. With the formation
of (9Z, 11E)-(13S)-13-hydroperoxyoctadeca-9,
11-dienoate, the changes in absorbance at 234 nm
were measured for 6 min. Test compounds and the
control were dissolved in methanol. All the reactions
were performed in triplicate in 96-well micro-plate
in SpectraMax 384 Plus (Molecular Devices, USA).
The IC50 values were then calculated using the EZFit Enzyme Kinetics program (Perrella Scientific Inc.,
Amherst, MA, USA). The percentage (%) inhibition
was calculated as follows:
% Inhibition = (E – S) / E × 100
where E = activity of the enzyme without test
compound
S = activity of enzyme with test compound.
Prolyl endopeptidase inhibition assay
PEP inhibition activity was assayed by a
modified method of Yoshimoto et al. (17); 100 mM
Tris (hydroxymethyl)-aminomethane HCl buffer
containing 1 mM EDTA (pH 7.0, 247 mL), PEP (0.02
units/well) 15 mL, and a stock solution of the test
compound in MeOH (8 mL, diluted to the desired
range of concentrations) were mixed in a 96-well
microplate and preincubated for 10 min at 30 °C.
The reaction was initiated by adding 30 μL of 0.2

mM of N-benzyloxycarbonyl-Gly-Pro-pNA (in 40%
1,4-dioxane) as the substrate. The amount of released
p-nitroaniline was measured spectrophotometrically,
as increase in absorption at 410 nm with 96-well
microplate reader (Molecular Devices, SpectraMax
340, USA). The percentage inhibition was calculated
by the following equation:
% Inhibition = 100 – [(O.D of test compound /
O.D of control) ´ 100]
The potency of enzyme inhibitory activity was
represented by the IC50 values, which were defined as
the concentration of the test compound that resulted
in 50% inhibition of the enzyme with respect to the
MeOH control. Z-Pro-prolinal was used as a positive
control.
Respiratory burst inhibitory assay
Respiratory burst inhibitory activity of test
compounds was determined by using the modified
assay of Tan et al. (18). This in vitro assay is based
on the reduction of highly water-soluble tetrazolium
salt (WST-1) in the presence of activated human
neutrophils. Heparinized fresh venous blood was
drawn from healthy volunteers in a local blood bank
and neutrophils were isolated by the method described
in previous publications (19,20). Activity was
determined in a total volume of 250 μL MHS (pH 7.4)
containing 1.0 × 104 neutrophils/mL, 500 μM WST-1,
and various concentrations of test compounds. The
control contained buffer, neutrophils, and WST-1.
All compounds were equilibrated at 37 °C and the
reaction was initiated by adding opsonized Zymosan
A (15 mg/mL), which was prepared by mixing with
human pooled serum, followed by centrifugation
at 3000 rpm and the pellet was resuspended in PBS
buffer. Absorbance was measured at 450 nm. Aspirin
and indomethacine were used as positive controls.
IC50 values were calculated by comparing with the
DMSO as blank and expressed as % inhibition of
superoxide anions produced. Absorbances were
measured on a SpectraMax 340 microplate reader
(Molecular Devices, CA, USA).
Results and discussion
Compound 1 (Figure) from the methanolic extract
of the leaves of M. paniculata was previously reported
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Figure. 2´-O-Ethylmurrangatin isolated from Murraya paniculata.

and also examined in terms of its anticholinesterase
activities (3). The structure of compound 1 was
identified on the basis of modern spectroscopic
methods. It was found to be 2´-O-ethylmurrangatin

The antioxidant activity of compound 1 was
evaluated by using a DPPH radical scavenging
assay. Propyl gallate was used as a positive control.
Compound 1 did not show any activity against DPPH
radicals.
Compound 1 was tested for lipoxygenase
inhibitory activity. Baicalein was used as a positive
control. Compound 1 exhibited significant activity
against the enzyme (Table).
Compound 1 was also screened for its enzyme
inhibitory activity against the prolyl endopeptidase
(PEP). It did not display inhibitory potential against
the PEP enzyme. Z-Pro-prolinal is used as a positive
control.
Respiratory burst inhibitory activity of compound
1 was evaluated by using a contemporary assay (18).
Indomethacine and aspirin, clinically used antiinflammatory drugs, were used as positive controls.
Compound 1 showed moderate activity, as compared
to standard at 400 mg/mL concentration (Table).

Table. In vitro DPPH radical scavenging, lipoxygenase, prolyl endopeptidase, and respiratory burst inhibitory activities
of compound 1, isolated from methanolic extract of Murraya paniculata.

1

2

3

4

% Inhibition
at 1 mM concentration for DPPH radical
scavenging activity

Compound 1

2.65%

Propyl gallate *

94.0%

IC50 (mM) ± S. E. M.
for lipoxygenase inhibitory activity

Compound 1

28.1 ± 0.8

Baicalein *

22.7 ± 0.5

IC50 (mM) ± S. E. M.
for prolyl endopeptidase (PEP) inhibitory activity

Compound 1

>1000

Z-Pro-prolinal *

880 ± 0.001

Compound 1

330.28 ± 2.46

Indomethacine *

271.21 ± 5.90

Aspirin *

50.30 ± 4.42

IC50 (mM) ± S. E. M. at 400 μg/mL concentration
for respiratory burst inhibitory activity

S. E. M. = Standard error of the mean of 5 assays
* = Positive control used in the assay
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